|1.||Hamilton, Andrew D: 1 article (05/2004)|
|2.||Lin, Qing: 1 article (05/2004)|
|3.||Paris, Daniel: 1 article (05/2004)|
|4.||Wotoczek-Obadia, Marguerite: 1 article (05/2004)|
|5.||Choi, Kihang: 1 article (05/2004)|
|6.||Jain, Rishi K: 1 article (05/2004)|
|7.||Delarue, Frederic: 1 article (05/2004)|
|8.||Sebti, Saïd M: 1 article (05/2004)|
|9.||Coppola, Domenico: 1 article (05/2004)|
|10.||Mullan, Michael: 1 article (05/2004)|
05/15/2004 - "In vivo, GFA-116 (50 mpk/day) inhibits tumor growth and angiogenesis as measured by CD31 staining of A-549 human lung tumors in nude mice. "
05/15/2004 - "Furthermore, GFA-116 is also effective at inhibiting tumor growth and metastasis to the lung of B16-F10 melanoma cells injected into immunocompetent mice. "
05/15/2004 - "From this library, we discovered GFA-116, which potently inhibits (125)I-VEGF binding to Flk-1 in Flk-1-overexpressing NIH 3T3 cells and human prostate tumor cells with an IC(50) of 750 nM. This inhibition is highly selective for VEGF in that (125)I- platelet-derived growth factor binding to its receptor is not affected. "
|2.||Neoplasm Metastasis (Metastasis)
|3.||Melanoma (Melanoma, Malignant)
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|2.||Platelet-Derived Growth Factor